13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q2 2021. See the latest, Q2 2026 →
Reported value
$53.74B
+6.7% on the quarter before
Positions
285
20 new · 25 sold out
Top 10
35.8%
of the value
Est. gain
+$2.95B
on stocks held all quarter
Est. return
+7.1%
on those stocks since Q1 2021
Positions as of Jun 30, 2021, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 60% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.
Largest buys
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Coinbase~$1.42BNew · 0.0% → 2.6%+5,617,415 shares
- UiPath~$806.7MNew · 0.0% → 1.5%+11,875,886 shares
- Draftkings Inc~$482.7MAdded · 0.5% → 1.3%+9,252,827 shares
- Tusimple Holdings Inc~$461.1MNew · 0.0% → 0.9%+6,472,735 shares
- Unity Software Inc~$407.9MAdded · 1.6% → 2.4%+3,713,575 shares
- Skillz Inc~$403.8MAdded · 0.2% → 1.0%+18,591,626 shares
- Twilio~$388.4MAdded · 1.9% → 2.7%+985,437 shares
- Twitter Inc~$318.1MAdded · 1.0% → 1.6%+4,622,845 shares
- Palantir~$317.6MAdded · 0.9% → 1.5%+12,049,327 shares
- Teladoc Health Inc~$264.9MAdded · 5.2% → 5.0%+1,592,818 shares
Largest sells
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baidu~$906.8MCut · 2.2% → 0.3%−4,447,307 shares
- Block~$716.5MCut · 5.0% → 3.6%−2,938,962 shares
- Intercontinental Exchange Inc~$565.9MCut · 1.2% → 0.2%−4,767,118 shares
- Synopsys~$380.8MCut · 0.8% → 0.1%−1,380,720 shares
- Everpure~$344.4MCut · 1.4% → 0.6%−17,633,366 shares
- Intellia Therapeutics Inc~$312.1MCut · 1.5% → 2.3%−1,927,470 shares
- Lendingtree Inc~$287.2MCut · 0.7% → 0.0%−1,723,085 shares
- Regeneron Pharmaceuticals Inc~$282.6MCut · 1.1% → 0.7%−505,922 shares
- Nvidia~$270.4MCut · 0.4% → 0.1%−337,900 shares
- Novartis Ag~$268.3MCut · 1.2% → 0.7%−2,944,567 shares
Holdings
As of Jun 30, 2021. Changes are in shares against Mar 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −6.1% · price +1.8% | 6.9% | $3.69B | +$64.0M | ||||||||
| Teladoc Health IncCommon Stock · shares +11% · price −8.5% | 5.0% | $2.66B | −$223.0M | ||||||||
| Roku IncCommon Stock · shares −5.1% · price +41.0% | 4.1% | $2.18B | +$632.9M | ||||||||
| BlockCommon Stock · shares −27% · price +7.4% | 3.6% | $1.96B | +$134.7M | ||||||||
| Shopify IncCommon Stock · shares +14% · price +32.0% | 3.3% | $1.78B | +$380.5M | ||||||||
| TwilioCommon Stock · shares +36% · price +15.7% | 2.7% | $1.47B | +$146.2M | ||||||||
| CoinbaseCommon Stock · shares New | 2.6% | $1.42B | — | ||||||||
| ZoomCommon Stock · shares +22% · price +20.5% | 2.6% | $1.42B | +$197.4M | ||||||||
| Exact Sciences CorpCommon Stock · shares +17% · price −5.7% | 2.5% | $1.33B | −$68.3M | ||||||||
| Spotify Technology SaCommon Stock · shares +23% · price +2.9% | 2.5% | $1.32B | +$29.7M | ||||||||
| Unity Software IncCommon Stock · shares +46% · price +9.5% | 2.4% | $1.30B | +$77.1M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −6.2% · price +32.9% | 2.3% | $1.26B | +$311.4M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares −20% · price +101.7% | 2.3% | $1.24B | +$627.5M | ||||||||
| Zillow Group IncCommon Stock · shares +1.2% · price −5.7% | 2.3% | $1.24B | −$74.4M | ||||||||
| Twitter IncCommon Stock · shares +59% · price +8.1% | 1.6% | $854.4M | +$40.4M | ||||||||
| 10x Genomics IncCommon Stock · shares +23% · price +8.2% | 1.6% | $842.0M | +$51.9M | ||||||||
| Beam Therapeutics IncCommon Stock · shares +35% · price +60.8% | 1.5% | $831.6M | +$232.6M | ||||||||
| PalantirCommon Stock · shares +65% · price +13.2% | 1.5% | $808.8M | +$57.2M | ||||||||
| UiPathCommon Stock · shares New | 1.5% | $806.7M | — | ||||||||
| DocuSignCommon Stock · shares −12% · price +38.1% | 1.5% | $784.8M | +$216.5M | ||||||||
| SeaADR · shares −11% · price +23.0% | 1.4% | $777.1M | +$145.4M | ||||||||
| Invitae CorpCommon Stock · shares −11% · price −11.7% | 1.3% | $721.8M | −$95.9M | ||||||||
| Pacific Biosciences Of CaliforCommon Stock · shares −3.8% · price +5.0% | 1.3% | $716.2M | +$34.0M | ||||||||
| Draftkings IncCommon Stock · shares +211% · price −14.9% | 1.3% | $711.0M | −$40.1M | ||||||||
| Twist Bioscience CorpCommon Stock · shares −16% · price +7.6% | 1.3% | $673.6M | +$47.5M | ||||||||
| Total · 285 positions | 100% | $53.74B | +$2.95B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2021 to Q2 2021: 264 stocks held throughout, up $2.95B (+7.1%).
- Roku Inc+$632.9M+41%
- Intellia Therapeutics Inc+$627.5M+102%
- Shopify Inc+$380.5M+32%
- Crispr Therapeutics Ag+$311.4M+33%
- Beam Therapeutics Inc+$232.6M+61%
- Veracyte Inc−$92.1M−26%
- Invitae Corp−$95.9M−12%
- Iovance Biotherapeutics Inc−$104.1M−18%
- Grayscale Bitcoin Trust Btc−$175.5M−40%
- Teladoc Health Inc−$223.0M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |